Company Profile
CEO
Mr. Robert A. Michael CPA(CEO & Chairman of the Board)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
57.0K
Beta
0.31
Forward P/E
13.8
52W High
$244.81
52W Low
$181.73
Profit Margin
5.8%
Operating Margin
32.2%
Return on Equity
--
Revenue Growth
12.4%
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment...
Valuation
Market Cap$393.91B
P/E (TTM)109.88
P/S (TTM)6.56
EV/EBITDA--
Cash Flow
FCF Yield+3.6%
SBC Adj. FCF Yield+3.2%
SBC Impact12.5%
Margins & Growth
Profit Margin4.6%
Operating Margin26.6%
Revenue YoY12.4%
Earnings YoY-46.0%
Balance
Cash$9.39B
Debt--
Net Cash--
Dividend
Dividend Yield3.13%
Payout Ratio444.0%
Quarterly Payout$3.09B